Prediabetes

Adults with heart failure assigned the SGLT2 inhibitor dapagliflozin had a 32% lower risk for new-onset type 2 diabetes over 18 months of follow-up vs. placebo, according to a planned analysis of DAPA-HF trial data.

The presence of type 2 diabetes was a significant risk factor for cognitive impairment following stroke, but investigators identified no association between prediabetes and cognitive function after stroke.

Elevated levels of the mineralocorticoids aldosterone and 11-deoxycorticosterone were associated with prediabetes and type 2 diabetes among adult participants in the Rural Henan Cohort study, according to findings published in the Journal of Diabetes and its Complications.

Community-based HbA1c testing in barbershops may help identify black men with undiagnosed diabetes, according to a research letter published in JAMA Internal Medicine.

Diabetes self-management education and support, or DSMES, the service offered by diabetes educators, improves HbA1c, reduces health system expenditures and decreases the risks for developing the acute and chronic complications associated with diabetes. Yet insurance companies report that most individuals with diabetes do not receive these services. Although this can be attributed to many factors, some of it directly relates to our very name, diabetes educator.

A large cohort of adults with chronic kidney disease, those with prediabetes were more likely to develop proteinuria or experience a cardiovascular event during 7 years of follow-up compared with those with normoglycemia, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

Prediabetes was less likely to progress to type 2 diabetes among adults who took a combination of linagliptin and metformin vs. metformin alone; the combination group was also more likely to achieve normal glucose levels, according to findings published in Metabolism.

Among Japanese adults with prediabetes who had normal weight, overweight or obesity, those who progressed to diabetes during an 8-year period had greater increases in BMI and waist circumference than those who maintained their prediabetes status or converted to normal glycemic levels, according to findings published in Clinical Nutrition.

Using HbA1c may not alter the effectiveness of screening for cardiovascular disease risk among adults with prediabetes, although CVD risk is greater among this group vs. those with lower HbA1c levels, according to findings published in Diabetes Care.

I tend to agree with most of my colleagues and say the way glucose monitoring is currently used, it has no value in this population. The data have no value unless they are perceived as actionable information that is reviewed by someone who knows what to do with the numbers. That is the issue.